Originally presented on September 11th, 2021 as a main session at the 2021 Virtual MDF Annual Conference.

Representatives from biotech and pharma companies will provide updates on their drug development efforts in the DM field. Day 2 features PepGen, NeuBase Therapeutics, ARTHEx biotech, and Expansion Therapeutics.

Speakers include:

• Jane Larkindale, PhD, PepGen
• Beatriz Llamusi, PhD, ARTHEx biotech
• Dietrich A. Stephan, PhD, NeuBase Therapeutics
• Valerie Cullen, PhD, Expansion Therapeutics